(Q42981626)

12 November 2017

title

Trans-complemented hepatitis C virus particles as a versatile tool for study of virus assembly and infection (English)

1 reference

12 November 2017

1 reference

9

Yoshiharu Matsuura

1 reference

12 November 2017

Ryosuke Suzuki

1

1 reference

12 November 2017

Kenji Saito

2

1 reference

12 November 2017

Takanobu Kato

3

1 reference

12 November 2017

Masayuki Shirakura

4

1 reference

12 November 2017

Daisuke Akazawa

5

1 reference

12 November 2017

Koji Ishii

6

1 reference

12 November 2017

Hideki Aizaki

7

1 reference

12 November 2017

Yumi Kanegae

8

1 reference

12 November 2017

Izumu Saito

10

1 reference

12 November 2017

Takaji Wakita

11

1 reference

12 November 2017

Tetsuro Suzuki

12

1 reference

12 November 2017

language of work or name

English

0 references

publication date

22 June 2012

1 reference

12 November 2017

1 reference

12 November 2017

volume

432

1 reference

12 November 2017

issue

1

1 reference

12 November 2017

page(s)

29-38

1 reference

Expression of hepatitis C virus (HCV) structural proteins in trans facilitates encapsidation and transmission of HCV subgenomic RNA.

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

CD81 Expression Is Important for the Permissiveness of Huh7 Cell Clones for Heterogeneous Hepatitis C Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Practical range of effective dose for Cre recombinase-expressing recombinant adenovirus without cell toxicity in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

The Tight Junction-Associated Protein Occludin Is Required for a Postbinding Step in Hepatitis C Virus Entry and Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Human Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell Culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

CD81 is an entry coreceptor for hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Diverse CD81 Proteins Support Hepatitis C Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Possible mechanism of adenovirus generation from a cloned viral genome tagged with nucleotides at its ends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Compensatory mutations in NS3 and NS5A proteins enhance the virus production capability of hepatitis C reporter virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Apolipoprotein E but Not B Is Required for the Formation of Infectious Hepatitis C Virus Particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

A genetic interaction between the core and NS3 proteins of hepatitis C virus is essential for production of infectious virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Mutations in the Yellow Fever Virus Nonstructural Protein NS2A Selectively Block Production of Infectious Particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Complete replication of hepatitis C virus in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Tight Junction Proteins Claudin-1 and Occludin Control Hepatitis C Virus Entry and Are Downregulated during Infection To Prevent Superinfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Complementation analysis of the flavivirus Kunjin NS3 and NS5 proteins defines the minimal regions essential for formation of a replication complex and shows a requirement of NS3 in cis for virus assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

NS3 Helicase Domains Involved in Infectious Intracellular Hepatitis C Virus Particle Assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Production of infectious hepatitis C virus by using RNA polymerase I-mediated transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Binding of hepatitis C virus to CD81

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Enhanced and specific gene expression via tissue-specific production of Cre recombinase using adenovirus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Efficient trans-Encapsidation of Hepatitis C Virus RNAs into Infectious Virus-Like Particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Hepatitis C viral life cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Replication-Competent Recombinant Vesicular Stomatitis Virus Encoding Hepatitis C Virus Envelope Proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Characterization of the envelope glycoproteins associated with infectious hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

Robust hepatitis C virus infection in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.05.033

10.1016/J.VIROL.2012.05.033

7 January 2021

Identifiers

DOI

1 reference

12 November 2017

1 reference